MoneyWorks4Me

The revenue for the March 2025 quarter is pegged at Rs. 6229.60 millions, about 11.34% up against Rs. 5595.30 millions recorded during the year-ago period.Profit for the quarter ended March 2025 rises by 70.12% to Rs. 614.80  millions from Rs. 361.40 millions.The company reported a good operating profit of 903.70 millions compared to 701.70 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 6229.60 5595.30 11.34 21736.50 22669.10 -4.11 21736.50 22669.10 -4.11
Other Income 17.10 11.10 54.05 135.80 41.80 224.88 135.80 41.80 224.88
PBIDT 903.70 701.70 28.79 2762.30 2703.10 2.19 2762.30 2703.10 2.19
Interest 74.80 80.90 -7.54 296.80 301.60 -1.59 296.80 301.60 -1.59
PBDT 828.90 620.80 33.52 2465.50 2401.50 2.67 2465.50 2401.50 2.67
Depreciation 122.10 123.40 -1.05 477.90 476.70 0.25 477.90 476.70 0.25
PBT 706.80 497.40 42.10 1987.60 1924.80 3.26 1987.60 1924.80 3.26
TAX 92.00 136.00 -32.35 414.50 506.00 -18.08 414.50 506.00 -18.08
Deferred Tax -5.00 -15.00 -66.67 35.00 10.00 250.00 35.00 10.00 250.00
PAT 614.80 361.40 70.12 1573.10 1418.80 10.88 1573.10 1418.80 10.88
Equity 912.70 919.40 -0.73 912.70 919.40 -0.73 912.70 919.40 -0.73
PBIDTM(%) 14.51 12.54 15.67 12.71 11.92 6.57 12.71 11.92 6.57
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..